CN Patent

CN1446229A — 促生长素抑制素类似物

Assigned to Recordati SA · Expires 2003-10-01 · 23y expired

What this patent protects

本发明提供了环[{4－(NH 2 －C 2 H 4 －NH－CO－O－)Pro}－Phg－DTrp－Lys－Tyr(4－苄基)－Phe]，其可以是保护的形式或是未保护的形式，或其可药用盐或络合物，其具有有益的药学特性。

USPTO Abstract

本发明提供了环[{4－(NH 2 －C 2 H 4 －NH－CO－O－)Pro}－Phg－DTrp－Lys－Tyr(4－苄基)－Phe]，其可以是保护的形式或是未保护的形式，或其可药用盐或络合物，其具有有益的药学特性。

Drugs covered by this patent

pasireotide-pamoate (PASIREOTIDE PAMOATE)

Patent Metadata

Patent number: CN1446229A
Jurisdiction: CN
Classification: —
Expires: 2003-10-01
Drug substance claim: No
Drug product claim: No
Assignee: Recordati SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.